Current role
Dr. Matthew Del Giudice
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Matthew Del Giudice
Telomir Pharmaceuticals, Inc. reported in an 8-K filed November 21, 2024 that Dr. Matthew Del Giudice was appointed member of the Audit Committee, effective November 20, 2024.
“On November 20, 2024, the Board of the Company unanimously approved the appointment of Dr. Matthew Del Giudice as a member of the Audit Committee, to fill the vacancy occasioned by the resignation of Mr. Jerman.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-11-20–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Telomir Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher Chapman CEO
- Erez Aminov CEO, Board Member
- Alan Weichselbaum CFO
- Andriy Mushak CFO
- Michelle Yanez CFO
- Edward MacPherson Board Member
- Matthew Del Giudice Board Member
- Matthew Del Giudice, M.D. Board Member
- Matthew Pratt Whalen Board Member
- Matthew Whalen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.